NVDA Bounces 2.3% but the Street's Conviction Is Slipping

NVIDIA added 2.3% on Tuesday to close at $206.69, a welcome reversal after a bruising week that left the stock down 5.2%. That weekly loss is actually less severe than the peer median of roughly 10%: AMD dropped 13.6% over the same five sessions, POET Technologies fell 10.5%, and HIMX shed 10.4%. NVIDIA underperformed on the way down from October's $241 peak, but it is holding up relatively better than its closest correlated names in the current pullback.

The lending market tells almost nothing useful here. Short interest has edged up fractionally, now at 1.26% of free float, on about 305 million shares short. That is a low and stable level, essentially unchanged from the 1.25% reported last week. Borrow availability is completely unconstrained, with billions of shares available relative to the modest short position. Cost to borrow has drifted back down to 0.28% after the brief spike to 0.70% on November 2. Options positioning is similarly uneventful: the put/call ratio at 1.01 is marginally below its 20-day average of 1.03, with a z-score near zero. None of this points to a directional bet forming in the derivatives or lending markets. The ORTEX short score of 30.4 has barely moved over the past two weeks.

The more interesting signal is in analyst sentiment. The Street remains broadly bullish, with a consensus mean price target of $327, implying roughly 58% upside from current levels. But the direction of travel on targets is downward. Melius Research's Ben Reitzes cut his target from $420 to $315 this week while keeping a Buy rating, the most recent concrete move and a 25% reduction in a single revision. The bull case rests on demand broadening beyond hyperscalers into enterprise agents and physical AI, with supply-chain commitments pointing to a 2.5x increase in substrate capacity and a more than 300% rise in interposer wafer capacity by 2028. The bear case centres on custom ASIC competition from Google and Amazon, the risk of an air pocket in data centre demand, and China embargo exposure. Valuation multiples reflect the tension: the P/E has compressed roughly 2.9 points over the past 30 days to 13.9x, and the price-to-book has fallen 1.8 points to 9.9x. The EPS momentum factor scores are healthy at 68 for the 30-day measure and 81 for the 90-day, but the 12-month forward year-on-year EPS increase ranks only in the 30th percentile, suggesting the market is pricing in a meaningful step-down in growth pace.

The last two earnings prints are worth having in mind. NVIDIA rose 7% the day after its August 2026 results and held most of that gain over five sessions. The print before that, in May, produced a 1.3% one-day decline followed by a 4.6% five-day loss. The next report is scheduled for November 17, thirteen days away. Wikipedia page views, the only real-time attention proxy in the alt data, have dropped sharply, with a z-score of minus 3.1 against the prior 90 days. That is unusually quiet for a company two weeks from an earnings date, and it may reflect genuine disengagement rather than a temporary lull.

Insider activity reinforces the cautious mood without being alarming. The 90-day net value of EDGAR Form 4 activity runs to roughly minus $968 million, driven largely by Director Mark Stevens selling more than 1.3 million shares in mid-September at around $220 and CFO Colette Kress selling just over $7.6 million across two tranches under a 10b5-1 plan. CEO Jen-Hsun Huang transferred 438,000 shares on September 17, a gift rather than an open-market sale, so it carries less informational weight. The Stevens sale was discretionary and therefore higher signal, though he is a long-standing holder and $220 was close to the prevailing market price at the time.

The number to watch on November 17 is revenue guidance for the following quarter, specifically whether management signals any softening in hyperscaler order cadence or any further China-related restrictions. At $206.69 the stock is 36% below the analyst consensus target, a gap wide enough that even a modest guidance disappointment could refresh selling pressure from holders rather than shorts.